Teva launches generic version of (Pr)Vesicare

Teva

Teva Canada Limited, which operates as a subsidiary of Teva Pharmaceutical Industries Ltd., has announced that it will be producing a generic version of (Pr)Vesicare called (Pr)Teva-Solifenacin. The drug is used to treat overactive bladder symptoms in adults, such as frequency, incontinence, and urgency. (Pr)Teva-Solifenacin has approval from Health Canada, and Teva Canada will be producing the only generic version available in the country.

Read the source article at ca.finance.yahoo.com

About the Author

Related Posts

Leave a Reply